What the global atmosphere is witnessing is the escalation of the new monkey epidemic, and also the raising of drug prices in Egypt by a decision of the Egyptian Medicine Authority. Entering the diverse winter season can be more difficult than summer is a paradise for Egyptian pharmaceutical companies listed on the Egyptian Stock Exchange From my personal...
Rapid change with almost certain assistance from its parent company What happened during the past period is like a miracle. The company transformed after the first quarter results showed huge losses and embezzlement charges that resulted in restructuring. After the distribution of closed dividends per share was suspended at 0.75 until liquidity was available, and...
Great reward to risk in this weekly chart setup in $GSK, worth a shot, you can probably play it with options to not allocate too much capital in this idea and have limited downside risk. An ITM put spread or some kind of Iron Butterfly OTM can both reap the passage of time profiting from Theta dropping and also give a positive reward to risk if carefully...
Will GSK hold this line? The ex div date is fast approaching, looks like a BUY on price action! My opinion only, not financial advice!
This is a low risk high reward gem. 90,000 employees is too many, look for a lay-off announcement to drive down price allowing for an ideal entry at $30.00
GlaxoSmithKlein (GSK) just formed a Death Cross on the 1D time-frame, which is when the 1D MA50 (blue trend-line) crosses below the 1D MA200 (orange trend-line). This is technically a bearish pattern but last time it formed (March 24 2020) was exactly on the bottom of the COVID crash and the price recovered rapidly. That was of course in the aftermath of the...
we have a 2 secnario in this chart secnario 1 : the big correction can be finished on 27.14 secnario 2: correction van be continues in the form of triangle and we are currently now in WD wave of triangle.
GSK is trading around the multi year lows having bounced off of the long term support zone at 1300. I think this is a relative bargain at these levels with GSK being one of the Big Pharma Companies that is still trading way below the starting price for the year. Pfizer, Johnson & Johnson and Roche are all either positive or around net zero YTD. Novartis is...
The stock has broken out and retested, therefore may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 2.5:1 SL is placed below support zone & the lower trendline. The target is placed near resistance.
BiondVax has signed definitive agreements with the Max Planck Society and the University Medical Center Göttingen to enter into a strategic collaboration for the development and commercialization of innovative COVID-19 nanosized antibodies (NanoAbs). NanoAbs exhibited in-vitro neutralization of all COVID-19 variants of concern including Delta, and based on...
GSK option trade. Expecting it to touch Yellow trend line. Momentum is really good.
good spot to long $GSK. set a progressive stop under yesterday's lows.
Based on historical movement, the trough could occur anywhere in the larger red box. The final targets are in the green boxes. The pending top should occur within the larger green box as has been the historical case. Half of all movement has ended in the smaller green box. In this instance, the signal indicated BUY on September 17, 2021 with a closing price of...
Glaxosmithkline ($GSK) testing the golden resistance level 1431.5 standing outside of the upper daily Bollinger Band. This level previously reversed Glaxosmithkline down in December of 2020 and in January of this year. Selected Alpha ranks the reversal factor of this resistance level 25 points – making it the strongest golden tracked by the system at the moment....
Amature trader here. There is a strong pattern on GSK which is now in wave IV of an ending diagonal. Price should go to 1170 but buy around 1200 to show confirmation of a new uptrend. See here: This is a weekly chart but over the next two years it may go up 660pts to 1900, could be worth a look this is not investment advice :), I've lost more than I've won, but...
Reward/Risk: 3.6/1 Entry: 100.00 or at a lower price Stop: 34.50 Target: 40.00 Options Play: March 19 37/38 Call Vertical
I previously posted a longterm stock position that I added to my portfolio. This was GSK (GlaxoSmithKline) which is trading at the lower levels of its range and has good growth potential but also a sturdy dividend yield of more than 5% each year. This stock has seen some strong bullish momentum this week and has broken out of a consolidation structure. The...
GSK London a good buy in many ways In Long Term (For Months) In Short Term (Days to Week) Nice Dividend Best